Rochelle G Prosser: Diversity, Equity, and Inclusion is not just a catch phrase
Rochelle G Prosser, Founder, CEO at Orchid Healthcare Solutions, shared a post by NCI, on LinkedIn, adding:
“What is clear from this National Cancer Institute (NCI) lethal prostate cancer study is something those of us in the African American communities often already know. Although we are all part of the human race, it is our differences in gene expression, characteristics and side effects that tell the true tale in cancer survival. DEI is not just a catch phrase. True clinical trial and cancer treatment Diversity and Inclusion will save all of humanity.”
Quoting NCI‘s post:
“An immune protein signature more often found in the blood of men of African ancestry is associated with an increased risk of lethal prostate cancer, according to a 2022 study led by NCI researchers.”
Source: Rochelle G Prosser/LinkedIn and NCI/LinkedIn
More posts featuring Rochelle G Prosser and NCI on oncodaily.com
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023